9 ms·
Cancer DNA is detectable in blood years before diagnosis
- bookofjoe 1y agohttps://archive.ph/uE18w https://archive.ph/uE18w
- andrewstuart 1y agoBlood testing sounds like a great opportunity for a startup…….
- adamors 1y agoI wonder if they could work with very small amounts of blood …?
- supportengineer 1y agoWhat if they took a small amount, but ran many different tests with it?
- sylens 1y agoWhat if the testing unit was so small it could sit on your kitchen counter and send the results digitally to your doctor?
- andrewstuart 1y agoWhat if major venture capitalists rallied around a charismatic founder and gave the startup huge financial backing.
- jjtheblunt 1y agothat made me chuckle. then i remembered a month or so ago seeing this, and not knowing what to make of it. https://siphoxhealth.com/ https://siphoxhealth.com/
- ada1981 1y agoHave you seen function health? It’s now a unicorn. As far as I can tell, they did a wholesale deal with quest diagnostics, and run your results through ChatGPT and give you supplement / diet recs via a pretty web portal 2x a year for $499. Claim is it’s 100 biomarkers and would cost avg person $15k retail. I’m a member and love it.
- andsoitis 1y agoAgelessRx offers the Galleri Multi-Cancer Early Detection test: https://agelessrx.com/galleri-multi-cancer-early-detection-test/ https://agelessrx.com/galleri-multi-cancer-early-detection-t... Ageless also provides many other longevity therapies.
- eej71 1y agoSome life insurance companies offered it for free as part of a service to existing clients. Mine claimed they would not know the results. I hope its true because I did take them up on the offer. Results were statistically favorable for me so I appreciate the test for what it is. Curious to see how these hold up over the long term.
- pnw 1y agoThat test is cheaper directly from https://www.galleri.com/ https://www.galleri.com/ ($799 vs $949). I get it every year. So far, so good!
- avgDev 1y agoQuite interesting to me and first time I am hearing about this. Question for you, what do you do when it shows you may have cancer? Do you speak to your physician? Surely, this will change your life even if it doesn't need treatment for next 6 years? Does the treatment change? Can the treatment be done based on those results? So many questions. I'm hoping we find more stuff for Alzheimer's. My aunt and now mother have it. I fear that I am next and I am too scared of doing the DNA test to check for genes.
- octaane 1y agoYou immediately bring the results to your doctor ASAP. They'll recommend follow-up testing since they want verification of third-party results and, well, are doctors and will know better about what to test for. If you do indeed have cancer, they will refer you to an oncologist who sub-specializes in that type of cancer.
- pnw 1y ago
- octaane 1y agoI actually know a little about this through my work. Cell-free DNA (CfDNA) Has been known about for a few decades, but has become more of a focus in recent years because of the advent of immunotherapies, which are often highly targeted drugs. CfDNA has also been used in "liquid biopsies" i.e, a simple blood draw, because it can help you profile the tumor and location of the cancer. In my field, we all think that CfDNA testing will eventually become a standard thing that will go along with your annual physical's blood test, because it has predictive/preventative abilities.
- drdrey 1y agohow actionable is the result? let's say you do detect trace amounts of tumoral DNA in your blood, what can you do? can you prevent it from developing into a full-on tumor if you don't even know where it is?
- datameta 1y agoI imagine the signature isn't simply binary but with several dimensions of differentiation?
- mikert89 1y agoThe big secret is that they could detect cancer very early in most people, but the health care companies don't want to pay for the screening. You can pay out of pocket for these procedures. I was told this by a cancer researcher EDIT: Adding these caveats: 1. There is a ton of nuance in the diagnosis, since most people have a small amount of cancer in their blood at all times 2. The screenings are 5-10k + follow up appointments to actually see if its real cancer 3. All in cost then could be much higher per person 4. These tests arent something that are currently produced to be used at mass scale
- melling 1y agoProbably not true. It’s much cheaper to catch cancer early than to treat advanced cancer later
- mikert89 1y agoNope, the cost is 5-10k maybe more, and there is alot of nuance and follow ups to those detections
- HPsquared 1y agoThat's true in the case someone actually does have cancer, but what about paying for all the negative tests?
- vasco 1y agoYeah but then you'd go through life having biopsies all the time. If all people did a full body MRI almost everyone would have weird lumps that doctors would have to biopsy to be really sure, and then what do you do? Do you biopsy yourself every time some weird tissue appears? Most of those will be nothing and you'll be going through the complications of surgeries and anesthesia all the time just to always make sure.
- rwmj 1y agoAssuming some future MRI technology which was very cheap, wouldn't you have MRIs at fairly regular intervals, to first see if the lump was growing or changing shape? And if this was being done at population scale, you'd train up an AI on the known outcomes, to have it flag up problems for a human to review.
- biotechbio 1y agoSome thoughts on this as someone working on circulating-tumor DNA for the last decade or so: - Sure, cancer can develop years before diagnosis. Pre-cancerous clones harboring somatic mutations can exist for decades before transformation into malignant disease. - The eternal challenge in ctDNA is achieving a "useful" sensitivity and specificity. For example, imagine you take some of your blood, extract the DNA floating in the plasma, hybrid-capture enrich for DNA in cancer driver genes, sequence super deep, call variants, do some filtering to remove noise and whatnot, and then you find some low allelic fraction mutations in TP53. What can you do about this? I don't know. Many of us have background somatic mutations speckled throughout our body as we age. Over age ~50, most of us are liable to have some kind of pre-cancerous clones in the esophagus, prostate, or blood (due to CHIP). Many of the popular MCED tests (e.g. Grail's Galleri) use signals other than mutations (e.g. methylation status) to improve this sensitivity / specificity profile, but I'm not convinced its actually good enough to be useful at the population level. - The cost-effectiveness of most follow on screening is not viable for the given sensitivity-specificity profile of MCED assays (Grail would disagree). To achieve this, we would need things like downstream screening to be drastically cheaper, or possibly a tiered non-invasive screening strategy with increasing specificity to be viable (e.g. Harbinger Health).
- tptacek 1y agoThis seems like yet another place where the base rate is going to fuck us: intuitively (and you've actually thought about this problem and I haven't) I'd expect that even with remarkably good tests, most people who come up positive will not go on to develop related disease.
- rscho 1y agoIdeally, you'd want a test (or two sequential ones) that's both very sensitive (rule candidates in) and specific (rule healthy peeps out). But that's only the first step, because there's no point knowing you're sick (from the populational and economic pov) if you can't do something useful about it. So you also have to include downstream tests and treatments in your assessment and all this suddenly becomes a very intricate probability network needing lots of data and thinking before decisions are made. And then, there's politics...
- siliconc0w 1y agoSadly health insurance in the US is unlikely to pay for most preventative care because the followup costs of false-positives and that they are betting that down the line someone else will pick up the tab when you get sick decades later (like the government). It's kind of why I'm favor of universal option to align financial incentives. Like given how sick the US population is, it probably makes sense to put a lot more people of GPL-1s and invest in improving their efficacy and permanence. Like nationalize-the-patent COVID-operational-warp-speed level urgency. There are over 100M Americans that are pre-diabetic, the cost of treating a diabetic is about 20k/yr. So $4 trillion in new costs, on top of the misery and human suffering.
- johnisgood 1y agoIt is sad that prevention is not something the US considers very important.
- ziml77 1y agoThey care about prevention but only if it's very cheap. I get emails all the time from my insurance company about joining their program that is supposed to help you live a healthier lifestyle.
- johnisgood 1y agoAny details on this program?
- jacobgkau 1y agoI started getting emails from Cigna about Omada after switching over to them last year. They pitch it as something you can sign up for to get health coaching. They (or their AI, soon if not already) provide that by sending you some "free" sensors (scale, pedometer, etc) and collecting lots of health information. Searching the web shows that Cigna forces some patients to use this program in order to receive coverage for certain conditions. They're likely saving all the info collected through it in order to use it to deny you coverage if they can at all make an argument that something was caused by your lifestyle, was pre-existing for a certain amount of time, etc-- at least, that's the vibe I got from researching it.
- cpncrunch 1y agoSeems like it might be overhyped. Here is the study https://aacrjournals.org/cancerdiscovery/article-abstract/doi/10.1158/2159-8290.CD-25-0375/763427/Detection-of-Cancers-Three-Years-prior-to https://aacrjournals.org/cancerdiscovery/article-abstract/do... Full text is paywalled, and no mention in abstract of false positive rate in control group. Has this test actually been independently verified? No mention of that important fact in the press release.
- ceph_ 1y agoA relative had this or a similar test come back positive. This sounds like a helpful signal on paper, but in reality it's not always actionable. They assumed their previous cancer had survived and metastasized. Doctors couldn't find the source. It turned into a waiting game, where they lived with a sword of Damocles over their head. They were retested every few months and monitored. Then after a year the tests the levels dropped off. And the end result was nothing came of it so far. It's normal to have some amount of pre-cancerous cells get naturally removed by your immune system. And this catches those too.
- tangerine_beet 1y agoSeems this newfound ability to detect cancers earlier than we thought possible could be used to develop better treatments to boost the body's innate ability to eliminate cancerous cells before they turn malign: 1) identify thousands of people with traces of cancerous DNA that are too weak to merit immediate action and who are willing to participate in a trial. 2) Divide them into two groups, one group gets for one month a daiiy dose of auricularia auricula fungus extract or whatever that is believed to possibly prevent cancers from developing, the other group gets a placebo. 3) Run the early-detection test again at the end of the month to see whether or not there is a difference in cancerous DNA signal strength between the two groups.
- elcritch 1y agoThat sort of thing would be awesome. I suspect it’d have to be community driven. Perhaps with some academics but who knows if IRBs would approve. Doing this same idea but with inflammation monitoring would be enormously valuable as well.
- Peteragain 1y agoHow to use such test results? I propose your GP knows your test results but you don't. You see the GP about a mole or something and the GP (not you) gets to decide on further tests / treatment, or sends you home saying don't worry about it.